Article Information
History
- February 23, 2023.
Article Versions
- You are currently viewing Version 1 of this article (February 23, 2023 - 12:07).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA, USA
- 2Shanghai Immune Therapy Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- 3Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA, USA
- 4Department of Life Sciences, University of Seoul, Seoul, South Korea
- ↵*Co-corresponding authors; email: jedixon{at}salk.edu